Categorynews

LabConnect Announces Appointment of Medical Director, Anthony Todd Everhart, MD, FACP

March 26, 2019 Off By BusinessWire

SEATTLE–(BUSINESS WIRE)–LabConnect,
a leading global provider of central laboratory and support services for
biopharmaceutical, pharmaceutical, medical device, and contract research
organizations, has appointed Dr.
Anthony Todd Everhart to serve as medical director. At LabConnect,
Dr. Everhart’s primary duties will be to serve as medical liaison to
central laboratory medical directors, expanding the use of visual
analytics, and advising Data Management and Scientific Affairs on data
integration, data normalization, and data harmonization. He will
contribute a wealth of industry skills and experience to LabConnect and
his appointment will bring yet another level of valuable expertise for
the clients of LabConnect’s premium central lab services.

According to LabConnect’s Chairman, Eric
Richman, “Dr. Everhart’s expertise is medical monitoring and
clinical data review for complex studies with experience in management
of over 30 clinical trials. In this era of ever-increasing data, his
focus has been on medical data review using visual analytics to ensure
and optimize data quality. We welcome his expertise in technology
adoption and in developing methodologies and tools for technology
implementation.”

Dr. Everhart is an innovator, educator, and leader in the pharmaceutical
and biotechnology industries, bringing over 11 years of experience in
complex clinical development to LabConnect. Prior to joining, he served
as vice president of medical informatics at Chiltern/Covance, vice
president of medical affairs Americas at Chiltern, and medical director
at Clinical Trial Management Services (CTMS). Board-certified in
internal medicine and a fellow of the American College of Physicians, he
has worked in all phases of clinical development in numerous therapeutic
areas including allergy and immunology, cardiovascular, hematology and
oncology, infectious disease and HIV, neurology, ophthalmology,
psychiatry, respiratory, and rheumatology.

LabConnect is pleased to add Dr. Everhart and his outstanding experience
to the LabConnect family.

For more information, visit labconnectllc.com.

About LabConnect
Founded in 2002, LabConnect provides global
central laboratory and client-inspired support services including
routine and specialized laboratory testing, kit building, sample
management and tracking, data management, biorepository and scientific
support services for biopharmaceutical and CRO clients. LabConnect’s
unique combination of state-of-the-art technology, world-class
laboratories, easy access to major and emerging markets and extensive
specialized testing expertise means that drug development companies can
rely on one provider for their central laboratory and preclinical
through Phase IV clinical development needs. Learn more at labconnectllc.com
or connect with LabConnect on LinkedIn.